Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

Cell

Volumn 171, Issue 2, 2017, Pages 273-285

  Stockwell, Brent R ^a   Friedmann Angeli, José Pedro ^b,z   Bayir, Hülya ^c   Bush, Ashley I ^d   Conrad, Marcus ^b   Dixon, Scott J ^e   Fulda, Simone ^f   Gascón, Sergio ^g,y   Hatzios, Stavroula K ^h   Kagan, Valerian E ⁱ   Noel, Kay ^j   Jiang, Xuejun ^k   Linkermann, Andreas ^l   Murphy, Maureen E ^m   Overholtzer, Michael ^k   Oyagi, Atsushi ⁿ   Pagnussat, Gabriela C ^o   Park, Jason ^p   Ran, Qitao ^q   Rosenfeld, Craig S ^j   Salnikow, Konstantin ^r   Tang, Daolin ^s,t   Torti, Frank M ^u   Torti, Suzy V ^u   Toyokuni, Shinya ^v   Woerpel, K A ^w   Zhang, Donna D ^x   more..

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e STANFORD UNIVERSITY   (United States)

^f GOETHE UNIVERSITY   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h YALE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j Collaborative Medicinal Development LLC ^*  (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^m WISTAR INSTITUTE   (United States)

ⁿ ONO PHARMACEUTICAL CO   (Japan)

^o UNIVERSIDAD NACIONAL DE MAR DEL PLATA   (Argentina)

^p FLAGSHIP PIONEERING   (United States)

^q UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^r NATIONAL CANCER INSTITUTE   (United States)

^s GUANGZHOU MEDICAL UNIVERSITY   (China)

^t UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^u UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^v NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^w NEW YORK UNIVERSITY   (United States)

^x UNIVERSITY OF ARIZONA   (United States)

^y Helmholtz Center Munich at the Biomedical Center   (Germany)

^z UNIVERSITY OF WÜRZBURG   (Germany)

more..

Author keywords

cancer; cell death; ferroptosis; glutathione; iron; metabolism; neurodegeneration; peroxidation; PUFA; ROS

Indexed keywords

REACTIVE OXYGEN METABOLITE; REAGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOL; TRANSCRIPTION FACTOR NRF2; UBIDECARENONE; IRON;

ALZHEIMER DISEASE; AMINO ACID METABOLISM; BRAIN HEMORRHAGE; CARCINOGENESIS; CELL DEATH; CEREBROVASCULAR ACCIDENT; DEMENTIA; FATTY ACID METABOLISM; FERROPTOSIS; GLUTATHIONE METABOLISM; HEAT STRESS; HUMAN; HUNTINGTON CHOREA; IRON METABOLISM; LIPID METABOLISM; LIPID PEROXIDATION; METABOLISM; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TRAUMATIC BRAIN INJURY; ANIMAL; APOPTOSIS;

ANIMALS; APOPTOSIS; CELL DEATH; HUMANS; IRON; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 85030552365     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.09.021     Document Type: Review

References (111)

1. Abrams, R.P., Carroll, W.L., Woerpel, K.A., Five-membered ring peroxide selectively initiates ferroptosis in cancer cells. ACS Chem. Biol. 11 (2016), 1305–1312.
2. Angeli, J.P.F., Shah, R., Pratt, D.A., Conrad, M., Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol. Sci. 38 (2017), 489–498.
3. Ayton, S., Fazlollahi, A., Bourgeat, P., Raniga, P., Ng, A., Lim, Y.Y., Diouf, I., Farquharson, S., Fripp, J., Ames, D., et al. Cerebral quantitative susceptibility mapping predicts β-amyloid-related cognitive decline. Brain 140 (2017), 2112–2119.
4. Bannai, S., Tsukeda, H., Okumura, H., Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium. Biochem. Biophys. Res. Commun. 74 (1977), 1582–1588.
5. Barelli, H., Antonny, B., Lipid unsaturation and organelle dynamics. Curr. Opin. Cell Biol. 41 (2016), 25–32.
6. Belaidi, A.A., Bush, A.I., Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics. J. Neurochem. 139:Suppl 1 (2016), 179–197.
7. Braak, H., Del Tredici, K., The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. Brain 138 (2015), 2814–2833.
8. Brettschneider, J., Del Tredici, K., Lee, V.M., Trojanowski, J.Q., Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat. Rev. Neurosci. 16 (2015), 109–120.
9. ∗-weighted phase imaging. Neurobiol. Aging 53 (2017), 20–26.
10. Cardoso, B.R., Hare, D.J., Bush, A.I., Roberts, B.R., Glutathione peroxidase 4: a new player in neurodegeneration?. Mol. Psychiatry 22 (2017), 328–335.
11. Cenini, G., Sultana, R., Memo, M., Butterfield, D.A., Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease. J. Cell. Mol. Med. 12 (2008), 987–994.
12. Chen, L., Hambright, W.S., Na, R., Ran, Q., Ablation of ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J. Biol. Chem. 290 (2015), 28097–28106.
13. Chiang, G.C., Mao, X., Kang, G., Chang, E., Pandya, S., Vallabhajosula, S., Isaacson, R., Ravdin, L.D., Shungu, D.C., Alzheimer's Disease Neuroimaging Initiative. Relationships among cortical glutathione levels, brain amyloidosis, and memory in healthy older adults investigated in vivo with (1)H-MRS and Pittsburgh compound-B PET. AJNR Am. J. Neuroradiol. 38 (2017), 1130–1137.
14. Conrad, M., Angeli, J.P., Vandenabeele, P., Stockwell, B.R., Regulated necrosis: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 15 (2016), 348–366.
15. Cramer, S.L., Saha, A., Liu, J., Tadi, S., Tiziani, S., Yan, W., Triplett, K., Lamb, C., Alters, S.E., Rowlinson, S., et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat. Med. 23 (2017), 120–127.
16. Crapper McLachlan, D.R., Dalton, A.J., Kruck, T.P.A., Bell, M.Y., Smith, W.L., Kalow, W., Andrews, D.F., Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337 (1991), 1304–1308.
17. Devos, D., Moreau, C., Devedjian, J.C., Kluza, J., Petrault, M., Laloux, C., Jonneaux, A., Ryckewaert, G., Garçon, G., Rouaix, N., et al. Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid. Redox Signal. 21 (2014), 195–210.
18. Di Domenico, F., Tramutola, A., Butterfield, D.A., Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic. Biol. Med. 111 (2017), 253–261.
19. Di Meco, A., Li, J.G., Blass, B.E., Abou-Gharbia, M., Lauretti, E., Praticò, D., 12/15-Lipoxygenase inhibition reverses cognitive impairment, brain amyloidosis, and tau pathology by stimulating autophagy in aged triple transgenic mice. Biol. Psychiatry 81 (2017), 92–100.
20. Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.C., Shao, F., Erratum: Pore-forming activity and structural autoinhibition of the gasdermin family. Nature, 540, 2016, 150.
21. Distéfano, A.M., Martin, M.V., Córdoba, J.P., Bellido, A.M., D'Ippólito, S., Colman, S.L., Soto, D., Roldán, J.A., Bartoli, C.G., Zabaleta, E.J., et al. Heat stress induces ferroptosis-like cell death in plants. J. Cell Biol. 216 (2017), 463–476.
22. Dixon, S.J., Stockwell, B.R., The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10 (2014), 9–17.
23. Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149 (2012), 1060–1072.
24. Dixon, S.J., Patel, D.N., Welsch, M., Skouta, R., Lee, E.D., Hayano, M., Thomas, A.G., Gleason, C.E., Tatonetti, N.P., Slusher, B.S., Stockwell, B.R., Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife, 3, 2014, e02523.
25. Dixon, S.J., Winter, G.E., Musavi, L.S., Lee, E.D., Snijder, B., Rebsamen, M., Superti-Furga, G., Stockwell, B.R., Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem. Biol. 10 (2015), 1604–1609.
26. Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC. Neurobiol. Dis. 94 (2016), 169–178.
27. Doll, S., Proneth, B., Tyurina, Y.Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13 (2017), 91–98.
28. Dolma, S., Lessnick, S.L., Hahn, W.C., Stockwell, B.R., Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3 (2003), 285–296.
29. Dysken, M.W., Sano, M., Asthana, S., Vertrees, J.E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G.D., McCarten, J.R., Malphurs, J., et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 311 (2014), 33–44.
30. Eagle, H., Nutrition needs of mammalian cells in tissue culture. Science 122 (1955), 501–514.
31. Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A., Brady, N.R., Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2 (2015), 517–532.
32. Enke, U., Seyfarth, L., Schleussner, E., Markert, U.R., Impact of PUFA on early immune and fetal development. Br. J. Nutr. 100 (2008), 1158–1168.
33. Fradejas, N., Carlson, B.A., Rijntjes, E., Becker, N.P., Tobe, R., Schweizer, U., Mammalian Trit1 is a tRNA([Ser]Sec)-isopentenyl transferase required for full selenoprotein expression. Biochem. J. 450 (2013), 427–432.
34. Friedmann Angeli, J.P., Schneider, M., Proneth, B., Tyurina, Y.Y., Tyurin, V.A., Hammond, V.J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16 (2014), 1180–1191.
35. Galluzzi, L., Bravo-San Pedro, J.M., Vitale, I., Aaronson, S.A., Abrams, J.M., Adam, D., Alnemri, E.S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 22 (2015), 58–73.
36. Gao, M., Monian, P., Quadri, N., Ramasamy, R., Jiang, X., Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell 59 (2015), 298–308.
37. Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., Jiang, X., Ferroptosis is an autophagic cell death process. Cell Res. 26 (2016), 1021–1032.
38. Gaschler, M.M., Stockwell, B.R., Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 482 (2017), 419–425.
39. Gascón, S., Murenu, E., Masserdotti, G., Ortega, F., Russo, G.L., Petrik, D., Deshpande, A., Heinrich, C., Karow, M., Robertson, S.P., et al. Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming. Cell Stem Cell 18 (2016), 396–409.
40. Gong, Y.N., Guy, C., Olauson, H., Becker, J.U., Yang, M., Fitzgerald, P., Linkermann, A., Green, D.R., ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences. Cell 169 (2017), 286–300.
41. Greenamyre, J.T., Penney, J.B., Young, A.B., D'Amato, C.J., Hicks, S.P., Shoulson, I., Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science 227 (1985), 1496–1499.
42. Greenshields, A.L., Shepherd, T.G., Hoskin, D.W., Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate. Mol. Carcinog. 56 (2017), 75–93.
43. Guiney, S.J., Adlard, P.A., Bush, A.I., Finkelstein, D.I., Ayton, S., Ferroptosis and cell death mechanisms in Parkinson's disease. Neurochem. Int. 104 (2017), 34–48.
44. Guo, J., Xu, B., Han, Q., Zhou, H., Xia, Y., Gong, C., Dai, X., Li, Z., Wu, G., Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res. Treat., 2017, 10.4143/crt.2016.572 Published online May 10, 2017.
45. Haas, U., Raschperger, E., Hamberg, M., Samuelsson, B., Tryggvason, K., Haeggström, J.Z., Targeted knock-down of a structurally atypical zebrafish 12S-lipoxygenase leads to severe impairment of embryonic development. Proc. Natl. Acad. Sci. USA 108 (2011), 20479–20484.
46. Hambright, W.S., Fonseca, R.S., Chen, L., Na, R., Ran, Q., Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol. 12 (2017), 8–17.
47. Hayano, M., Yang, W.S., Corn, C.K., Pagano, N.C., Stockwell, B.R., Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. 23 (2016), 270–278.
48. Heneka, M.T., Fink, A., Doblhammer, G., Effect of pioglitazone medication on the incidence of dementia. Ann. Neurol. 78 (2015), 284–294.
49. Hirayama, T., Nagasawa, H., Chemical tools for detecting Fe ions. J. Clin. Biochem. Nutr. 60 (2017), 39–48.
50. Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M.T., Zeh, H.J. 3rd, Kang, R., Tang, D., Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12 (2016), 1425–1428.
51. Jennis, M., Kung, C.P., Basu, S., Budina-Kolomets, A., Leu, J.I., Khaku, S., Scott, J.P., Cai, K.Q., Campbell, M.R., Porter, D.K., et al. An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev. 30 (2016), 918–930.
52. Jiang, L., Kon, N., Li, T., Wang, S.J., Su, T., Hibshoosh, H., Baer, R., Gu, W., Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520 (2015), 57–62.
53. Kagan, V.E., Mao, G., Qu, F., Angeli, J.P., Doll, S., Croix, C.S., Dar, H.H., Liu, B., Tyurin, V.A., Ritov, V.B., et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13 (2017), 81–90.
54. Kerins, M.J., Ooi, A., The roles of NRF2 in modulating cellular iron homeostasis. Antioxid. Redox Signal., 2017, 10.1089/ars.2017.7176 Published online August 10, 2017.
55. Khanna, S., Roy, S., Ryu, H., Bahadduri, P., Swaan, P.W., Ratan, R.R., Sen, C.K., Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J. Biol. Chem. 278 (2003), 43508–43515.
56. Kim, S.E., Zhang, L., Ma, K., Riegman, M., Chen, F., Ingold, I., Conrad, M., Turker, M.Z., Gao, M., Jiang, X., et al. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat. Nanotechnol. 11 (2016), 977–985.
57. Krainz, T., Gaschler, M.M., Lim, C., Sacher, J.R., Stockwell, B.R., Wipf, P., A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis. ACS Cent. Sci. 2 (2016), 653–659.
58. Kuhn, H., Banthiya, S., van Leyen, K., Mammalian lipoxygenases and their biological relevance. Biochim. Biophys. Acta 1851 (2015), 308–330.
59. Li, Q., Han, X., Lan, X., Gao, Y., Wan, J., Durham, F., Cheng, T., Yang, J., Wang, Z., Jiang, C., et al. Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI Insight, 2, 2017, e90777.
60. Linkermann, A., Bräsen, J.H., Darding, M., Jin, M.K., Sanz, A.B., Heller, J.O., De Zen, F., Weinlich, R., Ortiz, A., Walczak, H., et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 110 (2013), 12024–12029.
61. Linkermann, A., Skouta, R., Himmerkus, N., Mulay, S.R., Dewitz, C., De Zen, F., Prokai, A., Zuchtriegel, G., Krombach, F., Welz, P.S., et al. Synchronized renal tubular cell death involves ferroptosis. Proc. Natl. Acad. Sci. USA 111 (2014), 16836–16841.
62. Liu, D.S., Duong, C.P., Haupt, S., Montgomery, K.G., House, C.M., Azar, W.J., Pearson, H.B., Fisher, O.M., Read, M., Guerra, G.R., et al. Inhibiting the system xC(-)/glutathione axis selectively targets cancers with mutant-p53 accumulation. Nat. Commun., 8, 2017, 14844.
63. MacLeod, A.K., McMahon, M., Plummer, S.M., Higgins, L.G., Penning, T.M., Igarashi, K., Hayes, J.D., Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 30 (2009), 1571–1580.
64. Mancias, J.D., Wang, X., Gygi, S.P., Harper, J.W., Kimmelman, A.C., Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509 (2014), 105–109.
65. Mandal, P.K., Saharan, S., Tripathi, M., Murari, G., Brain glutathione levels-a novel biomarker for mild cognitive impairment and Alzheimer's disease. Biol. Psychiatry 78 (2015), 702–710.
66. −-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. FASEB J. 25 (2011), 1359–1369.
67. McCullagh, E.A., Featherstone, D.E., Behavioral characterization of system xc- mutant mice. Behav. Brain Res. 265 (2014), 1–11.
68. Milne, G.L., Sanchez, S.C., Musiek, E.S., Morrow, J.D., Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc. 2 (2007), 221–226.
69. Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2 (1989), 1547–1558.
70. Newton, K., Dugger, D.L., Maltzman, A., Greve, J.M., Hedehus, M., Martin-McNulty, B., Carano, R.A., Cao, T.C., van Bruggen, N., Bernstein, L., et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23 (2016), 1565–1576.
71. Ou, Y., Wang, S.J., Li, D., Chu, B., Gu, W., Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc. Natl. Acad. Sci. USA 113 (2016), E6806–E6812.
72. Prasad, M.R., Lovell, M.A., Yatin, M., Dhillon, H., Markesbery, W.R., Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23 (1998), 81–88.
73. Raven, E.P., Lu, P.H., Tishler, T.A., Heydari, P., Bartzokis, G., Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. J. Alzheimers Dis. 37 (2013), 127–136.
74. Revett, T.J., Baker, G.B., Jhamandas, J., Kar, S., Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J. Psychiatry Neurosci. 38 (2013), 6–23.
75. Sato, H., Shiiya, A., Kimata, M., Maebara, K., Tamba, M., Sakakura, Y., Makino, N., Sugiyama, F., Yagami, K., Moriguchi, T., et al. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem. 280 (2005), 37423–37429.
76. Seiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E.K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8 (2008), 237–248.
77. Shimada, K., Hayano, M., Pagano, N.C., Stockwell, B.R., Cell-line selectivity improves the predictive power of pharmacogenomic analyses and helps identify NADPH as biomarker for ferroptosis sensitivity. Cell Chem. Biol. 23 (2016), 225–235.
78. Shimada, K., Skouta, R., Kaplan, A., Yang, W.S., Hayano, M., Dixon, S.J., Brown, L.M., Valenzuela, C.A., Wolpaw, A.J., Stockwell, B.R., Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12 (2016), 497–503.
79. Skouta, R., Dixon, S.J., Wang, J., Dunn, D.E., Orman, M., Shimada, K., Rosenberg, P.A., Lo, D.C., Weinberg, J.M., Linkermann, A., Stockwell, B.R., Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 136 (2014), 4551–4556.
80. Song, X., Xie, Y., Kang, R., Hou, W., Sun, X., Epperly, M.W., Greenberger, J.S., Tang, D., FANCD2 protects against bone marrow injury from ferroptosis. Biochem. Biophys. Res. Commun. 480 (2016), 443–449.
81. Spangler, B., Morgan, C.W., Fontaine, S.D., Vander Wal, M.N., Chang, C.J., Wells, J.A., Renslo, A.R., A reactivity-based probe of the intracellular labile ferrous iron pool. Nat. Chem. Biol. 12 (2016), 680–685.
82. Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., Wang, H., Cao, L., Tang, D., HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene 34 (2015), 5617–5625.
83. Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., Tang, D., Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology 64 (2016), 488–500.
84. Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., Tang, D., Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63 (2016), 173–184.
85. Sydenham, E., Dangour, A.D., Lim, W.S., Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst. Rev.(6), 2012, CD005379.
86. Tonnus, W., Linkermann, A., The in vivo evidence for regulated necrosis. Immunol. Rev. 277 (2017), 128–149.
87. Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., Akatsuka, S., Iron and thiol redox signaling in cancer: An exquisite balance to escape ferroptosis. Free Radic. Biol. Med. 108 (2017), 610–626.
88. Tuo, Q.-Z., Lei, P., Jackman, K.A., Li, X.L., Xiong, H., Li, X.-L., Liuyang, Z.-Y., Roisman, L., Zhang, S.-T., Ayton, S., et al. Tau-mediated iron export prevents ferroptotic damage after ischemic stroke. Mol. Psychiatry, 2017, 10.1038/mp.2017.171 Published online September 8, 2017.
89. Ursini, F., Maiorino, M., Valente, M., Ferri, L., Gregolin, C., Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim. Biophys. Acta 710 (1982), 197–211.
90. van den Brink-van der Laan, E., Killian, J.A., de Kruijff, B., Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile. Biochim. Biophys. Acta 1666 (2004), 275–288.
91. Vanden Berghe, T., Vanlangenakker, N., Parthoens, E., Deckers, W., Devos, M., Festjens, N., Guerin, C.J., Brunk, U.T., Declercq, W., Vandenabeele, P., Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ. 17 (2010), 922–930.
92. Viswanathan, V.S., Ryan, M.J., Dhruv, H.D., Gill, S., Eichhoff, O.M., Seashore-Ludlow, B., Kaffenberger, S.D., Eaton, J.K., Shimada, K., Aguirre, A.J., et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547 (2017), 453–457.
93. Wan, C., Li, S., Wen, L., Kong, J., Wang, K., Zhu, Y., Damage of oxidative stress on mitochondria during microspores development in Honglian CMS line of rice. Plant Cell Rep. 26 (2007), 373–382.
94. Wang, D., Peng, Y., Xie, Y., Zhou, B., Sun, X., Kang, R., Tang, D., Antiferroptotic activity of non-oxidative dopamine. Biochem. Biophys. Res. Commun. 480 (2016), 602–607.
95. Wang, Y.Q., Chang, S.Y., Wu, Q., Gou, Y.J., Jia, L., Cui, Y.M., Yu, P., Shi, Z.H., Wu, W.S., Gao, G., Chang, Y.Z., The protective role of mitochondrial ferritin on erastin-induced ferroptosis. Front. Aging Neurosci., 8, 2016, 308.
96. Wang, H., An, P., Xie, E., Wu, Q., Fang, X., Gao, H., Zhang, Z., Li, Y., Wang, X., Zhang, J., et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology 66 (2017), 449–465.
97. Williams, T.I., Lynn, B.C., Markesbery, W.R., Lovell, M.A., Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol. Aging 27 (2006), 1094–1099.
98. Wolpaw, A.J., Shimada, K., Skouta, R., Welsch, M.E., Akavia, U.D., Pe'er, D., Shaik, F., Bulinski, J.C., Stockwell, B.R., Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc. Natl. Acad. Sci. USA 108 (2011), E771–E780.
99. Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., Tang, D., Ferroptosis: process and function. Cell Death Differ. 23 (2016), 369–379.
100. Xie, Y., Song, X., Sun, X., Huang, J., Zhong, M., Lotze, M.T., Zeh, H.J. 3rd, Kang, R., Tang, D., Identification of baicalein as a ferroptosis inhibitor by natural product library screening. Biochem. Biophys. Res. Commun. 473 (2016), 775–780.
101. Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T.R., et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity. Cell Rep. 20 (2017), 1692–1704.
102. Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A.J., Yang, W.S., Fridman, D.J., Wolpaw, A.J., Smukste, I., Peltier, J.M., Boniface, J.J., et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447 (2007), 864–868.
103. Yang, W.S., Stockwell, B.R., Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15 (2008), 234–245.
104. Yang, W.S., Stockwell, B.R., Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26 (2016), 165–176.
105. Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., Cheah, J.H., Clemons, P.A., Shamji, A.F., Clish, C.B., et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156 (2014), 317–331.
106. Yang, W.S., Kim, K.J., Gaschler, M.M., Patel, M., Shchepinov, M.S., Stockwell, B.R., Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. USA 113 (2016), E4966–E4975.
107. Yoo, S.E., Chen, L., Na, R., Liu, Y., Rios, C., Van Remmen, H., Richardson, A., Ran, Q., Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain. Free Radic. Biol. Med. 52 (2012), 1820–1827.
108. Yuan, H., Li, X., Zhang, X., Kang, R., Tang, D., CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochem. Biophys. Res. Commun. 478 (2016), 838–844.
109. Yuan, H., Li, X., Zhang, X., Kang, R., Tang, D., Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem. Biophys. Res. Commun. 478 (2016), 1338–1343.
110. Zilka, O., Shah, R., Li, B., Friedmann Angeli, J.P., Griesser, M., Conrad, M., Pratt, D.A., On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent. Sci. 3 (2017), 232–243.
111. Zille, M., Karuppagounder, S.S., Chen, Y., Gough, P.J., Bertin, J., Finger, J., Milner, T.A., Jonas, E.A., Ratan, R.R., Neuronal death after hemorrhagic stroke in vitro and in vivo shares features of ferroptosis and necroptosis. Stroke 48 (2017), 1033–1043.